Equities Analysts Issue Forecasts for MacroGenics Inc’s FY2019 Earnings (MGNX)
MacroGenics Inc (NASDAQ:MGNX) – Equities researchers at Leerink Swann boosted their FY2019 earnings per share estimates for shares of MacroGenics in a research note issued to investors on Monday, November 12th, according to Zacks Investment Research. Leerink Swann analyst J. Chang now expects that the biopharmaceutical company will post earnings of ($2.08) per share for the year, up from their previous estimate of ($4.07).